| 1 | 1797336 | Effects of the glycine prodrug milacemide (2-N-pentylaminoacetamide) on catecholamine secretion from isolated adrenal medulla chromaffin cells. | Br J Pharmacol | 1991 Nov |
1 |
| 2 | 2420928 | Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl. | J Neurochem | 1986 May |
1 |
| 3 | 3499585 | 1-Methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine (MCTP): an alicyclic MPTP-like neurotoxin. | Neurosci Lett | 1987 Aug 18 |
3 |
| 4 | 3935467 | Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B. | Eur J Pharmacol | 1985 Oct 22 |
1 |
| 5 | 6793119 | Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B. | Br J Pharmacol | 1981 May |
1 |
| 6 | 8988465 | Pharmacology and neuroprotective properties of rasagiline. | J Neural Transm Suppl | 1996 |
1 |
| 7 | 9559942 | Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor. | Neuroreport | 1998 Mar 9 |
1 |
| 8 | 9564627 | Chronic TVP-1012 (rasagiline) dose--activity response of monoamine oxidases A and B in the brain of the common marmoset. | J Neural Transm Suppl | 1998 |
1 |
| 9 | 9564628 | Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkey. | J Neural Transm Suppl | 1998 |
1 |
| 10 | 9564629 | Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. | J Neural Transm Suppl | 1998 |
1 |
| 11 | 9564630 | (R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B. | J Neural Transm Suppl | 1998 |
1 |
| 12 | 9632221 | Sparing by rasagiline (TVP-1012) of cholinergic functions and behavior in the postnatal anoxia rat. | Pharmacol Biochem Behav | 1998 Jun |
1 |
| 13 | 10082192 | Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse. | Eur J Pharmacol | 1999 Feb 5 |
1 |
| 14 | 10518120 | Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation. | J Neurosci Res | 1999 Nov 1 |
7 |
| 15 | 10907720 | Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat. | J Neural Transm (Vienna) | 1999 |
2 |
| 16 | 10993123 | Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat. | Life Sci | 2000 Jun 23 |
3 |
| 17 | 10996018 | Mechanism underlying anti-apoptotic activity of a (-)deprenyl-related propargylamine, rasagiline. | Mech Ageing Dev | 2000 Jul 31 |
2 |
| 18 | 11159700 | Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. | Br J Pharmacol | 2001 Jan |
10 |
| 19 | 11192605 | The neuronal survival effects of rasagiline and deprenyl on fetal human and rat ventral mesencephalic neurones in culture. | Neuroreport | 2000 Dec 18 |
1 |
| 20 | 11205137 | TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease. | J Neural Transm Suppl | 2000 |
2 |
| 21 | 11462767 | Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs. | Ann N Y Acad Sci | 2001 Jun |
2 |
| 22 | 11462787 | Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022. | Ann N Y Acad Sci | 2001 Jun |
2 |
| 23 | 11462801 | The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo. | Ann N Y Acad Sci | 2001 Jun |
1 |
| 24 | 11520893 | Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. | J Neurochem | 2001 Aug |
3 |
| 25 | 11575866 | Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa. | Clin Neuropharmacol | 2000 Nov-Dec |
1 |
| 26 | 11716145 | Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats. | J Neural Transm (Vienna) | 2001 |
1 |
| 27 | 11716151 | Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. | J Neural Transm (Vienna) | 2001 |
1 |
| 28 | 11779573 | Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells. | Eur J Pharmacol | 2002 Jan 11 |
1 |
| 29 | 11795516 | Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy. | Ann N Y Acad Sci | 2001 Apr |
2 |
| 30 | 11956966 | The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells. | J Neural Transm (Vienna) | 2002 Apr |
1 |
| 31 | 12039419 | Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease. | Parkinsonism Relat Disord | 2002 Mar |
3 |
| 32 | 12043833 | Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]. | Cell Mol Neurobiol | 2001 Dec |
4 |
| 33 | 12044957 | Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline. | Mech Ageing Dev | 2002 Apr 30 |
1 |
| 34 | 12057839 | An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells. | Neurosci Lett | 2002 Jun 28 |
5 |
| 35 | 12090555 | Rasagiline. Teva Pharmaceutical. | Curr Opin Investig Drugs | 2002 May |
1 |
| 36 | 12200198 | Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes. | Neurotoxicol Teratol | 2002 Sep-Oct |
3 |
| 37 | 12206996 | Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline. | FASEB J | 2002 Oct |
1 |
| 38 | 12358797 | Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan. | J Neurochem | 2002 Aug |
1 |
| 39 | 12433110 | Determination of the norepinephrine level by high-performance liquid chromatography to assess the protective effect of MAO-B inhibitors against DSP-4 toxicity. | J Chromatogr Sci | 2002 Oct |
2 |
| 40 | 12470183 | A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study. | Arch Neurol | 2002 Dec |
1 |
| 41 | 12504917 | Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours. | Neuropharmacology | 2002 Dec |
2 |
| 42 | 12697291 | Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor. | Neurosci Lett | 2003 May 8 |
1 |
| 43 | 12871751 | Pharmacological comparison between the actions of methamphetamine and 1-aminoindan stereoisomers on sympathetic nervous function in rat vas deferens. | Eur J Pharmacol | 2003 Jul 11 |
1 |
| 44 | 12943198 | Synthesis and initial results for MAO-B inhibition by new N-propargyl-3-pyrrol-1-ylindanamine derivatives, analogues of rasagiline. | J Enzyme Inhib Med Chem | 2003 Apr |
2 |
| 45 | 14525944 | The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing. | FASEB J | 2003 Dec |
5 |
| 46 | 14555244 | The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline. | Biochem Pharmacol | 2003 Oct 15 |
14 |
| 47 | 14687604 | N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor. | Neurochem Int | 2004 May |
8 |
| 48 | 14696044 | Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease? | Bioessays | 2004 Jan |
1 |
| 49 | 14732458 | Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline. | Neurosci Lett | 2004 Jan 30 |
4 |
| 50 | 15027867 | Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. | J Med Chem | 2004 Mar 25 |
7 |